Tenecteplase: biochemical and clot lysis activity comparisons
Taken together, these data demonstrate that the tenecteplase copy Mingfule<sup>®</sup> has several meaningful fibrinolytic and biochemical differences compared with Metalyse<sup>®</sup>. This raises the question of whether data from clinical studies with one of the products can be generalized for all tenecteplase variants.
Authors
- Jan Bechmann
- I. Schmid
- Simone Brand
- Felix D. Miller
- Chengzhi Zhang (ORCID: https://orcid.org/0000-0002-7367-0334)
Institutions
- Boehringer Ingelheim (Germany) (DE)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3389/fphar.2024.1498116
- Citations
- 1
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.29
Funders
- Boehringer Ingelheim